Stay updated on Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.
Latest updates to the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check7 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference1%
- Check44 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference1%
- Check51 days agoChange DetectedDifference1%
- Check58 days agoChange DetectedSeveral key URLs related to genetics, clinical trials, and drug information have been removed, indicating a significant reduction in available resources for users seeking information on prostate cancer and related treatments.SummaryDifference2%
Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.